Company / SG&A per Share
GeneDx Holdings Corp. SG&A per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$5.38
FY2025
5-year range
$4.02 / $1661193.55
FY2021-FY2025
Trend
+33.8%
vs FY2024
Sector context
#80 of 150
Health Care
What the data says
At $5.38, GeneDx Holdings Corp.'s sg&a per share ranks #71 of 150 in the Health Care sector. SG&A per Share returned to growth in FY2025 after 3 years of decline, reaching $5.38.
Based on SEC 10-K filings.
5.38 in FY2025 with a 5-year CAGR of -80.6%.
Improved from $11.81 to $5.38 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -95.0%
- 5-Year CAGR
- -80.6%
- 10-Year CAGR
- -
Sector benchmark
#71 of 150 in Health CareTop 47% of 150This company $5.38 Sector average $11878.17
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 33.8% year-over-year.
- Ranks #80 out of 150 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2021.
- Lowest sg&a per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.38 | +33.8% |
| FY2024 | $4.02 | -65.9% |
| FY2023 | $11.81 | -100.0% |
| FY2022 | $42129.60 | -97.5% |
| FY2021 | $1661193.55 | +8360.8% |
| FY2020 | $19633.99 | -91.7% |
| FY2019 | $237774.19 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026